NeuroSense Therapeutics NRSN
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.77 | -2 | 1 | |||
| 2025Q2 | 1.89 | -1 | 2 | |||
| 2024Q4 | 1.20 | 3 | -2 | -64.80 | 5 | |
| 2024Q3 | 1.27 | -3 | -2 | -152.07 | 1 | |
| 2024Q2 | 1.12 | -2 | -1 | -52.14 | 2 | |
| 2024Q1 | 1.82 | -7 | -5 | -233.84 | 1 | |
| 2023Q4 | 0.79 | -2 | -3 | -68.84 | 3 | |
| 2023Q3 | 0.71 | 0 | 1 | 11.83 | 5 | |
| 2023Q2 | 1.49 | -2 | -5 | -79.15 | 8 | |
| 2023Q1 | 1.72 | 3 | -68.74 | -3 | -44.83 | 5 |
| 2022Q4 | 1.22 | 6 | -46.79 | -3 | -37.19 | 8 |
| 2022Q3 | 1.79 | 8 | -33.86 | -3 | -28.95 | 9 |
| 2022Q2 | 3.38 | 10 | -31.73 | -3 | -26.97 | 11 |
| 2022Q1 | 3.97 | 12 | -25.72 | -3 | -21.06 | 14 |
| 2021Q4 | 2.46 | 9 | 0 | 11 | ||
| 2021Q3 | -1 | |||||
| 2021Q2 | 1 | -1 | 1 | |||
| 2021Q1 | -2 | |||||
| 2020Q4 | 1 | 1 |